“…The exact causes of muscle weakness and atrophy induced by doxorubicin remain poorly understood, and doxorubicin-treated rodents have been used to investigate these phenomena. In these models, muscle weakness and fiber alterations (proteolysis, autophagy, apoptosis) have been described, with variations depending on the mode of administration (intraperitoneal versus intravenous) and the type of muscle (soleus, extensor digitorum longus, heart, diaphragm) (Gilliam et al, 2009(Gilliam et al, , 2012(Gilliam et al, , 2013De Angelis et al, 2010;Smuder et al, 2011a,b;DirksNaylor et al, 2013;Kavazis et al, 2014;Yu et al, 2014). These studies show evidence that muscle fibers as well as the (n = 8).…”